Technical Analysis for SWTX - SpringWorks Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| Historical SWTX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 20 DMA | Bearish | 0.00% | |
| Multiple of Ten Bearish | Other | 0.00% | |
| 20 DMA Support | Bullish | -3.31% | |
| Multiple of Ten Bearish | Other | -3.31% | |
| Outside Day | Range Expansion | -3.31% | |
| Upper Bollinger Band Touch | Strength | -3.31% | |
| New 52 Week Closing High | Bullish | -8.06% | |
| Multiple of Ten Bullish | Other | -8.06% | |
| 20 DMA Support | Bullish | -4.88% | |
| 180 Bullish Setup | Bullish Swing Setup | -4.88% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| 60 Minute Opening Range Breakdown | 3 days ago | |
| 20 DMA Support | 3 days ago | |
| Down 3% | 3 days ago | |
| Down 2 % | 3 days ago | |
| Down 1% | 3 days ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Springworks Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It identifies pathways for drug development for patients with severe rare diseases and cancer. The firm's products include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is headquartered in Stamford, CT.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmaceutical Industry Pharmacy Rare Diseases Drug Development
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmaceutical Industry Pharmacy Rare Diseases Drug Development
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 96.48 |
| 52 Week Low | 19.5 |
| Average Volume | 311,249 |
| 200-Day Moving Average | 56.71 |
| 50-Day Moving Average | 80.20 |
| 20-Day Moving Average | 88.06 |
| 10-Day Moving Average | 88.61 |
| Average True Range | 5.71 |
| ADX | 27.88 |
| +DI | 19.05 |
| -DI | 18.56 |
| Chandelier Exit (Long, 3 ATRs ) | 79.35 |
| Chandelier Exit (Short, 3 ATRs ) | 94.72 |
| Upper Bollinger Band | 94.83 |
| Lower Bollinger Band | 81.30 |
| Percent B (%b) | 0.35 |
| BandWidth | 15.36 |
| MACD Line | 2.65 |
| MACD Signal Line | 3.27 |
| MACD Histogram | -0.6196 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 95.41 | ||||
| Resistance 3 (R3) | 96.11 | 93.69 | 93.85 | ||
| Resistance 2 (R2) | 93.69 | 91.31 | 93.34 | 93.33 | |
| Resistance 1 (R1) | 89.87 | 89.83 | 88.66 | 89.17 | 92.81 |
| Pivot Point | 87.45 | 87.45 | 86.85 | 87.10 | 87.45 |
| Support 1 (S1) | 83.63 | 85.07 | 82.42 | 82.93 | 79.29 |
| Support 2 (S2) | 81.21 | 83.59 | 80.86 | 78.77 | |
| Support 3 (S3) | 77.39 | 81.21 | 78.25 | ||
| Support 4 (S4) | 76.69 |
